These results indicate that inhibiting cytoplasmic inflammasome assembly favors NLRP3 nuclear localization, binding to the il-4 promoter and positive regulation of IL-4 expression in CD4+ T cells from CTCL. This evidence concerns the gene NLRP3 and primary cutaneous T-cell non-Hodgkin lymphoma.